Myriad Genetics | MYGN - Marktkapitalisierung

Aktienkurs
4.35
Täglich Wechseln
-0.09 -2.03%
Monatlich
-14.03%
Jährlich
-45.63%
Q2 Prognose
4.23




Marktkapitalisierung Veränderung Datum
Agilent USD 37.86B 3.64B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Bio-Rad Laboratories USD 8.21B 601M 2025-12
Bruker USD 7.16B 2.23B 2025-12
Danaher USD 161.7B 29.34B 2025-12
Hologic USD 16.62B 1.67B 2025-12
Illumina USD 20.62B 6.53B 2025-12
J&J USD 500.24B 67.44B 2025-12
Mettler Toledo International USD 28.48B 3.19B 2025-12
Myriad Genetics USD 575M 98M 2025-12
OraSure Technologies USD 174M 61M 2025-12
Pacific Biosciences Of California USD 565M 180M 2025-12
Quest Diagnostics USD 19.3B 2.01B 2025-12
Quidel USD 1.99B 66M 2025-12
Repligen USD 9.22B 1.7B 2025-12
Revvity USD 10.97B 1.21B 2025-12
Standard Biotools USD 492M 5M 2025-12
Thermo Fisher Scientific USD 217.7B 42.4B 2025-12
Veracyte USD 3.33B 627M 2025-12
Waters USD 22.61B 5.25B 2025-12